- Home
- REAX vs CSTL Comparison
REAX vs CSTL Comparison
Compare REAX & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAX
- CSTL
- Stock Information
- Founded
- REAX 2018
- CSTL 2007
- Country
- REAX United States
- CSTL United States
- Employees
- REAX N/A
- CSTL N/A
- Industry
- REAX
- CSTL Medical Specialities
- Sector
- REAX
- CSTL Health Care
- Exchange
- REAX Nasdaq
- CSTL Nasdaq
- Market Cap
- REAX 820.5M
- CSTL 661.7M
- IPO Year
- REAX N/A
- CSTL 2019
- Fundamental
- Price
- REAX $3.60
- CSTL $34.11
- Analyst Decision
- REAX Strong Buy
- CSTL Strong Buy
- Analyst Count
- REAX 3
- CSTL 6
- Target Price
- REAX $6.33
- CSTL $38.67
- AVG Volume (30 Days)
- REAX 1.6M
- CSTL 457.3K
- Earning Date
- REAX 10-30-2025
- CSTL 11-03-2025
- Dividend Yield
- REAX N/A
- CSTL N/A
- EPS Growth
- REAX N/A
- CSTL N/A
- EPS
- REAX N/A
- CSTL N/A
- Revenue
- REAX $1,813,907,000.00
- CSTL $343,530,000.00
- Revenue This Year
- REAX $55.78
- CSTL N/A
- Revenue Next Year
- REAX $22.39
- CSTL N/A
- P/E Ratio
- REAX N/A
- CSTL N/A
- Revenue Growth
- REAX 65.60
- CSTL 10.15
- 52 Week Low
- REAX $3.42
- CSTL $14.59
- 52 Week High
- REAX $5.65
- CSTL $35.49
- Technical
- Relative Strength Index (RSI)
- REAX 41.67
- CSTL 74.88
- Support Level
- REAX $3.60
- CSTL $32.96
- Resistance Level
- REAX $4.16
- CSTL $35.49
- Average True Range (ATR)
- REAX 0.21
- CSTL 1.72
- MACD
- REAX 0.03
- CSTL 0.42
- Stochastic Oscillator
- REAX 27.89
- CSTL 88.44
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.